Literature DB >> 9171939

Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.

A Abdel-Mageed1, K C Agrawal.   

Abstract

The association of increased metallothionein (MT) gene expression in breast cancer with metastasis and poor prognosis has led us to investigate the hypothesis that inhibition of MT gene expression may elicit antiproliferative effects in breast carcinoma MCF7 cells. To monitor the effect of downregulation of MT protein on growth, MCF7 cells were transiently transfected by electroporation with an 18-mer MT antisense phosphorothioate oligomer (AO) or an 18-mer random oligomer (RO). The MT-AO is complementary to the region 7 bases downstream from the AUG translational start site of the hMT-IIA gene. Transfection of MCE7 cells with the AO inhibited cell growth by 50-60% at 72 hours when compared to control cells or the cells transfected with RO. The AO-induced growth inhibition was associated with alterations in morphology suggestive of apoptotic cell death. This was further confirmed by DNA linker cleavage into oligonucleosomal fragments and decreased bcl-2 protein levels in AO-transfected cells as opposed to the RO-transfected cells. Reverse transcriptase polymerase chain reaction analysis showed that AO induced a 2-fold increase in the levels of c-fos and p53 transcripts in comparison to RO which had no significant effect. Conversely, c-myc transcripts were decreased by 2.5-fold in the AO-transfected cells when compared to the controls. Furthermore, MCF7 cells transfected with an expression plasmid pBAcNEO-sMT-IIA encompassing human MT-IIA cDNA, constitutively driven by beta-actin promotor, caused a 2.5-fold increase in intracellular levels of MT, as judged by PCR and western blot analysis, in comparison to the cells transfected with pBAcNEO plasmid. In contrast to the AO-induced growth inhibition, overexpression of cytoplasmic MT increased the cell multiplication by 2-fold compared with control cells or the cells transfected with the control plasmid 72 hours post-transfection. Moreover, the effects of AO on oncogene expression were reversed on increased expression of MT. These data suggest that overexpression of MT potentiates the growth of MCF7 cells, whereas downregulation of MT elicits antiproliferative effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171939

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  19 in total

1.  The role of metallothionein IIa in defending lens epithelial cells against cadmium and TBHP induced oxidative stress.

Authors:  John R Hawse; Vanita A Padgaonkar; Victor R Leverenz; Sara E Pelliccia; Marc Kantorow; Frank J Giblin
Journal:  Mol Vis       Date:  2006-04-17       Impact factor: 2.367

Review 2.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Authors:  Adrian K West; Juan Hidalgo; Donnie Eddins; Edward D Levin; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-01-19       Impact factor: 4.294

3.  The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.

Authors:  J M M Tan; E P C Tock; V T K Chow
Journal:  Mol Pathol       Date:  2003-04

4.  Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers.

Authors:  Pheruza Tarapore; Yi Shu; Peixuan Guo; Shuk-Mei Ho
Journal:  Mol Ther       Date:  2010-11-09       Impact factor: 11.454

5.  Heavy metal-induced metallothionein expression is regulated by specific protein phosphatase 2A complexes.

Authors:  Liping Chen; Lu Ma; Qing Bai; Xiaonian Zhu; Jinmiao Zhang; Qing Wei; Daochuan Li; Chen Gao; Jie Li; Zhengbao Zhang; Caixia Liu; Zhini He; Xiaowen Zeng; Aihua Zhang; Weidong Qu; Zhixiong Zhuang; Wen Chen; Yongmei Xiao
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

6.  Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.

Authors:  Siew-Kian Tai; Owen June-Keong Tan; Vincent Tak-Kwong Chow; Rongxian Jin; J Louise Jones; Puay-Hoon Tan; Anita Jayasurya; Boon-Huat Bay
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

7.  NF-kappaB-dependent gene expression of proinflammatory cytokines in T24 cells: possible role in interstitial cystitis.

Authors:  Asim B Abdel-Mageed; Ali Bajwa; Behnam B Shenassa; Liset Human; Gamal M Ghoniem
Journal:  Urol Res       Date:  2003-07-11

8.  Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.

Authors:  Matthias Bruewer; Kurt W Schmid; Christian F Krieglstein; Norbert Senninger; Guido Schuermann
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

9.  Gene expression profiles in HPV-immortalized human cervical cells treated with the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Bogdan Prokopczyk; Indu Sinha; Neil Trushin; Willard M Freeman; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2008-11-06       Impact factor: 5.192

Review 10.  Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer.

Authors:  Samina Alam; Shannon L Kelleher
Journal:  Nutrients       Date:  2012-07-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.